LOTUSEYEBSELotus Eye Hospital And Institute LtdMinimalNeutral
Announced Thu, 28 May · 13:03 IST

Annual Secretarial Compliance Report for the financial year ended March 31, 2026.

LOTUSEYE · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
-1.8%1-day move
₹110.00
prior close
₹107.60
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+0.0+2.1+2.1-0.6-1.8-0.5+1.8+0.0+11.8+10.9+16.4+10.5
Up moveDown movePending
AI summary

Lotus Eye Hospital And Institute Ltd has filed its Annual Secretarial Compliance Report for FY 2025-26, prepared by P. Eswaramoorthy and Company. The report shows the company is largely compliant with SEBI regulations. One current compliance gap was identified: the company failed to intimate the appointment of Secretarial Auditor and Internal Auditor to stock exchanges under Regulation 30. Additionally, BSE and NSE had levied fines for prior non-compliance under Regulation 17(1A) regarding delay in obtaining shareholder approval for appointment of Dr. K.S. Ramalingam as Non-Executive Director; this was subsequently regularized through fine payment and shareholder approval via postal ballot. The company has no subsidiaries.

Likely market impact

The filing indicates minor regulatory lapses that were subsequently corrected. Current non-disclosure regarding auditor appointments may attract regulatory attention but does not pose significant risk as other governance standards appear sound.